Sponsor:
National Institutes of Health
Updated Date:
Jun 6, 2019
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
General Notices
- Notice of Informational Webinar on the Intramural NIGMS Postdoctoral Research Associate Training (PRAT) Program and Fi2 Application Process
National Institute of General Medical Sciences
- Notice of Pre-Application Webinar for RFA-RM-19-004 Sponsored Programs Administration Development (SPAD) Program (UC2)
National Institute of General Medical Sciences
- Notice of Information for RFA-HL-20-009, "BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa (UG3/UH3 CT Optional)"
National Heart, Lung, and Blood Institute
- Notice of Information for RFA-HL-20-010, "BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa-DCC (U24 CT Not Allowed)"
National Heart, Lung, and Blood Institute
Notice of Changes to Funding Opportunities
- Notice of Correction to RFA-CA-19-033 "Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required)"
National Cancer Institute
- Notice of Change to PAR-18-437"Cutting-Edge Basic Research Awards (CEBRA) (R21-Clinical Trial Optional)"
National Institute on Drug Abuse
- Notice of Clarification of Institutional Eligibility for RFA-RM-19-004 "Sponsored Programs Administration Development (SPAD) Program (UC2)
National Institute of General Medical Sciences
Notices of Special Interest
- Notice of Special Interest for Small Business in Genomic Medicine Research
National Human Genome Research Institute
Funding Opportunities
- Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed)
National Institute of Mental Health
- Oscillatory Patterns of Gene Expression in Aging and Alzheimers Disease (R01 Clinical Trial Not Allowed)
National Institute on Aging
- Immunobiology of Xenotransplantation (U01 Clinical Trial Not Allowed)
- Immunobiology of Xenotransplantation (U19 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
- National Drug Early Warning System Coordinating Center (U01 Clinical Trial Optional )
National Institute on Drug Abuse
- Exploiting In Vivo Precision Pharmacology Techniques to Understand Opioid Receptor Signaling in Specific Circuits, Cell Types, and Subcellular Compartments (R61/R33 - Clinical Trial Not Allowed)
National Institute on Drug Abuse
- Adipogenesis, Adipocyte Function and Obesity Following HIV Infection, Antiretroviral Therapy, or Pre-Exposure Prophylaxis (R01 Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases
- Implementation of U.S. Food Safety Modernization Act - Identifying, Researching, and Implementing Alternative Methods to Expand the Reach across the Global Supply Chain (U01) - Clinical Trials Not Allowed
Food and Drug Administration
- Renewal Application: Critical Path Public Private Partnerships (U18) Clinical Trials Optional
Food and Drug Administration
- Cigar Tobacco Reference Products Program (UC2) Clinical Trials Not Allowed
Food and Drug Administration
- Brain Initiative: Research to Develop and Validate Advanced Human Cell-Based Assays To Model Brain Structure and Function (R01 Clinical Trial Not Allowed)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
- Research Program Award (R35 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Lynn Hudachek at lynn-hudachek @uiowa.edu or Erin Brothers at erin-brothers@uiowa.edu